PENTIXAPHARM HOLDING AG (PTP.DE) Stock Price & Overview
FRA:PTP • DE000A40AEG0
Current stock price
The current stock price of PTP.DE is 1.892 EUR. Today PTP.DE is up by 2.83%. In the past month the price decreased by -9.04%. In the past year, price decreased by -41.78%.
PTP.DE Key Statistics
- Market Cap
- 46.922M
- P/E
- N/A
- Fwd P/E
- N/A
- EPS (TTM)
- -0.86
- Dividend Yield
- N/A
PTP.DE Stock Performance
PTP.DE Stock Chart
PTP.DE Technical Analysis
ChartMill assigns a technical rating of 1 / 10 to PTP.DE. When comparing the yearly performance of all stocks, PTP.DE is a bad performer in the overall market: 81.46% of all stocks are doing better.
PTP.DE Fundamental Analysis
ChartMill assigns a fundamental rating of 2 / 10 to PTP.DE. PTP.DE has a great financial health rating, but its profitability evaluates not so good.
PTP.DE Earnings
PTP.DE Forecast & Estimates
5 analysts have analysed PTP.DE and the average price target is 11.95 EUR. This implies a price increase of 531.84% is expected in the next year compared to the current price of 1.892.
PTP.DE Groups
Sector & Classification
PTP.DE Financial Highlights
Over the last trailing twelve months PTP.DE reported a non-GAAP Earnings per Share(EPS) of -0.86.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -59.32% | ||
| ROE | -69.4% | ||
| Debt/Equity | 0 |
PTP.DE Ownership
PTP.DE Competitors/Peers
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| 1EL | ESSILORLUXOTTICA | 25.31 | 90.272B | ||
| EL | ESSILORLUXOTTICA | 25.68 | 90.249B | ||
| ESL | ESSILORLUXOTTICA | 25.19 | 89.832B | ||
| CVX | CARVOLIX SA | N/A | 187.198M | ||
| GBT | GUERBET | N/A | 123.872M | ||
| ALCJ | CROSSJECT | 5.5 | 105.257M |
Related stock screener links
View all stocks in the Health Care Supplies Industry | View all stocks in the Health Care Sector | View all stocks on the Frankfurt Stock Exchange Exchange | Find stocks with similar TA and Setup ratings on the European exchanges | Find stocks with similar Fundamental rating on the European exchanges | Find the competitors with the best technical ratings on the European exchanges | Find the competitors with the best fundamentals on the European exchanges | Find the competitors with the best valuation on the European exchanges | Find the competitors with the best dividend on the European exchanges | Find the competitors with the best analyst ratings on the European exchanges
About PTP.DE
Company Profile
Pentixapharm Holding AG engages in the development of radiopharmaceutical approaches for diagnostic and therapeutic programs in a number of hematological and solid cancers, as well as cardiovascular, endocrine, and inflammatory diseases. The company is headquartered in Berlin, Berlin and currently employs 64 full-time employees. The company went IPO on 2024-10-03. The firm focuses on the development of radiopharmaceuticals for various therapeutic areas, as well as for the diagnosis and therapy (theranostics) of blood cancer and others. The company is also engaged in holding activities and is also involved in the research and development of drugs for hematological and solid cancers, as well as cardiovascular, endocrine and inflammatory diseases.
Company Info
IPO: 2024-10-03
PENTIXAPHARM HOLDING AG
Robert-Roessle-Strasse 10
Berlin BERLIN DE
Employees: 64
Phone: 493094893220
PENTIXAPHARM HOLDING AG / PTP.DE FAQ
What does PENTIXAPHARM HOLDING AG do?
Pentixapharm Holding AG engages in the development of radiopharmaceutical approaches for diagnostic and therapeutic programs in a number of hematological and solid cancers, as well as cardiovascular, endocrine, and inflammatory diseases. The company is headquartered in Berlin, Berlin and currently employs 64 full-time employees. The company went IPO on 2024-10-03. The firm focuses on the development of radiopharmaceuticals for various therapeutic areas, as well as for the diagnosis and therapy (theranostics) of blood cancer and others. The company is also engaged in holding activities and is also involved in the research and development of drugs for hematological and solid cancers, as well as cardiovascular, endocrine and inflammatory diseases.
What is the stock price of PENTIXAPHARM HOLDING AG today?
The current stock price of PTP.DE is 1.892 EUR. The price increased by 2.83% in the last trading session.
Does PENTIXAPHARM HOLDING AG pay dividends?
PTP.DE does not pay a dividend.
What is the ChartMill technical and fundamental rating of PTP stock?
PTP.DE has a ChartMill Technical rating of 1 out of 10 and a ChartMill Fundamental rating of 2 out of 10.
What is the Price/Earnings (PE) ratio of PENTIXAPHARM HOLDING AG (PTP.DE)?
PENTIXAPHARM HOLDING AG (PTP.DE) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.86).
Would investing in PENTIXAPHARM HOLDING AG be a good decision?
This depends on your investment goals. Check the Technical and Fundamental Analysis tabs for insights on PTP.DE.
What is PENTIXAPHARM HOLDING AG worth?
PENTIXAPHARM HOLDING AG (PTP.DE) has a market capitalization of 46.92M EUR. This makes PTP.DE a Nano Cap stock.